GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genix Pharmaceuticals Corp (TSXV:GENX) » Definitions » Total Assets

Genix Pharmaceuticals (TSXV:GENX) Total Assets : C$0.23 Mil (As of Jul. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Genix Pharmaceuticals Total Assets?

Genix Pharmaceuticals's Total Assets for the quarter that ended in Jul. 2024 was C$0.23 Mil.

During the past 12 months, Genix Pharmaceuticals's average Total Assets Growth Rate was -94.20% per year. During the past 3 years, the average Total Assets Growth Rate was -64.30% per year. During the past 5 years, the average Total Assets Growth Rate was 76.00% per year. During the past 10 years, the average Total Assets Growth Rate was 17.00% per year.

During the past 13 years, Genix Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 678.40%. The lowest was -70.20%. And the median was -6.90%.

Total Assets is connected with ROA %. Genix Pharmaceuticals's annualized ROA % for the quarter that ended in Jul. 2024 was -136.67%. Total Assets is also linked to Revenue through Asset Turnover. Genix Pharmaceuticals's Asset Turnover for the quarter that ended in Jul. 2024 was 0.00.


Genix Pharmaceuticals Total Assets Historical Data

The historical data trend for Genix Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genix Pharmaceuticals Total Assets Chart

Genix Pharmaceuticals Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 5.35 4.77 4.25 0.22

Genix Pharmaceuticals Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.84 0.22 0.25 0.25 0.23

Genix Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Genix Pharmaceuticals's Total Assets for the fiscal year that ended in Oct. 2023 is calculated as

Total Assets=Total Equity (A: Oct. 2023 )+Total Liabilities (A: Oct. 2023 )
=-1.137+1.361
=0.22

Genix Pharmaceuticals's Total Assets for the quarter that ended in Jul. 2024 is calculated as

Total Assets=Total Equity (Q: Jul. 2024 )+Total Liabilities (Q: Jul. 2024 )
=-1.365+1.597
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genix Pharmaceuticals  (TSXV:GENX) Total Assets Explanation

Total Assets is connected with ROA %.

Genix Pharmaceuticals's annualized ROA % for the quarter that ended in Jul. 2024 is

ROA %=Net Income (Q: Jul. 2024 )/( (Total Assets (Q: Apr. 2024 )+Total Assets (Q: Jul. 2024 ))/ count )
=-0.328/( (0.247+0.233)/ 2 )
=-0.328/0.24
=-136.67 %

Note: The Net Income data used here is four times the quarterly (Jul. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Genix Pharmaceuticals's Asset Turnover for the quarter that ended in Jul. 2024 is

Asset Turnover
=Revenue (Q: Jul. 2024 )/( (Total Assets (Q: Apr. 2024 )+Total Assets (Q: Jul. 2024 ))/ count )
=0.001/( (0.247+0.233)/ 2 )
=0.001/0.24
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Genix Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of Genix Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Genix Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8
Genix Pharmaceuticals Corp is a Canadian life sciences company. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals.
Executives
Sina Pirooz Director
Paul Chow 10% Security Holder, Director
Jamie A. Lewin Director

Genix Pharmaceuticals Headlines

No Headlines